Amplicor HIV monitor, NASBA HIV-1 RNA QT and quantiplex HIV RNA version 2.0 viral load assays: A Canadian evaluation

Journal of Clinical Virology

Volumn 11, Issue 3, 1998, Pages 189-202

  Prud'Homme, I T ^a   Kim, J E ^a   Pilon, R G ^b   Minkus, T ^a   Hawley Foss, N ^b   Cameron, W ^b   Rud, E W ^a  

^a LAB CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

HIV 1 RNA; Plasma RNA level; RNA quantitation; Viral load

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; ASSAY; BLOOD SAMPLING; CANADA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; VIRUS LOAD;

ADOLESCENT; ADULT; CANADA; CD4 LYMPHOCYTE COUNT; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; VIRAL LOAD; VIROLOGY;

EID: 0032416689     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(98)00058-0     Document Type: Article

References (35)

1. Allies A., Lidman K., Sönnerborg A., Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS. 11:1997;859-865.
2. Aoki-Sei S., Yarchoan R.Y., Kageyama S., Hoekzema D.T., Pluda J.M., Wyvill K.M., Broder S., Mitsuya H. Plasma viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res Hum Retroviruses. 8:1992;1263-1270.
3. Brambilla D., Leug S., Lew J., Todd J., Herman S., Cronin M., Shapiro D.E., Bremer J., Hanson C., Hillyer G.V., McSherry G.D., Sperling R.S., Coombs R.W., Reichelderfer P.S. Absolute copy number and relative change in determination of human immunodeficiency virus type 1 RNA in plasma: effect of an external standard on kit comparison. J Clin Microbiol. 36(1):1998;311-314.
4. Bruisten S.M., Koppelman M.H., Roos M.T., Loeliger A.E., Reiss P., Boucher C.A., Huisman H.G. Use of a competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments. AIDS. 7(Suppl 2):1993;S15-S20.
5. Cohen O.J., Pantaleo G., Holodniy M., Schnittman S., Niu M., Graziosi C., Pavlakis G.N., Lalezar J., Barletti J.A., Steigbigel R.T., Cohn J., Novak R., McMahon D., Fauci A.S. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc Natl Acad Sci USA. 92:1995;6017-6021.
6. Collins M.L., Irvine B., Tyner D., Fine E., Zayati C., Chang C., Horn T., Ahle D., Shen L.-P., Kolberg J., Bushnell S., Urdea M.S., Ho D.D. A branched DNA signal amplification assay for quantification of nucleic targets below 100 molecules/ml. Nucleic Acids Res. 25:1997;2979-2984.
7. Coste J., Montes B., Reynes J., Peeters M., Segarra C., Vendrell J.-P., Delaporte E., Segondy M. Comparative evaluation of three assays for the quantitation of human immmunodeficiency virus type 1 RNA in plasma. J Med Virol. 50:1996;293-302.
8. Dunne A., Crowe S.M. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS. 11:1997;126-127.
9. Gobbers E., Fransen K., Oosterlaken T., Janssens W., Heyndrickx L., Ivens T., Veereecken K., Schoones R., van de Wiel P., van der Groen G. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J Virol Methods. 66:1997;293-301.
10. Holodniy M., Katzenstein D.A., Sengupta S., Wang A.M., Casipit C., Schwartz D.H., Konrad M., Groves E., Merigan T.C. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of polymerase chain reaction. J Infect Dis. 163:1991;862-866.
11. Iluano R., Forastieri G., Brizzi M., Mecocci L., Mazzotta F., Ceccherini-Nelli L. Correlation between plasma HIV-1 RNA levels and the rate of immunological decline. J AIDS Hum Retroviruses. 14:1997;408-414.
12. Kern D., Collins M., Fultz T., Detmer J., Hamren S., Peterkin J.J., Todd J. An enhanced-sensitivity branched-DNA assay for the quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 12:1996;3196-3202.
13. Layne S.P., Merges M.J., Dembo M., Spouge J.L., Conley S.R., Moore J.P., Raina J.L., Renz H., Gelderblom H.R., Nara P.L. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology. 189(2):1992;695-714.
14. Lin H.J., Myers L.E., Yen-Lieberman B., Hollinger F.B., Henrard D., Hooper C.J., Kokka R., Kwok S., Rasheed S., Vahey M., Winters M.A., McQuay L.J., Nara P.L., Reicherderfer R., Coombs R.W., Jackson J.B. Multicenter evaluation of quantitation methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis. 170:1994;553-562.
15. Lousert-Akaja I., Deschamps D., Simon F., Brun-Vezinet F., Ekwalanga M., Saragosti S. Genetic diversity and HIV detection by polymerase chain reaction. Lancet. 346:1995;912-913.
16. Mellors J.W., Kingsley L.A., Rinaldo C.R., Todd J.A., Hoo B.S., Kokka R., Gupta P. Quantitative of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 122:1995;573-579.
17. Mulder J., Resnick R., Saget B., Scheibel S., Herman S., Payne H., Harrigan R., Kwok S. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA in plasma: enhanced sensitivity. J Clin Microbiol. 35:1997;1278-1280.
18. Mulder J., McKinney N., Christopherson C., Sninsky J., Greenfield L., Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol. 32:1994;292-300.
19. Veterans Affairs Cooperative Study on AIDS, O'Brien W.A., Hartigan P.M., Martin D., Esinhart J., Hill A., Benoit S., Rubin M., Simberkoff S.M., Hamilton J.D. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New Engl J Med. 334:1996;426-431.
20. Palch C., Todd J.A., Kern D.G., Sheridan P.J., Fong S.-J., Stempien M., Hoo B., Besemer D., Yerghiazarian T., Irvine B., Kolberg J., Kokka R., Neuwald P., Urdea M.S. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acq Hum Immune Deficiency Syndrome Hum Retrovirol. 8:1994;446-454.
21. Piatak M. Jr., Saag M.S., Yang L.C., Clarck S.J., Kappes J.C., Luk K.-C., Hahn B.H., Shaw G.M., Lifson J.D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 259:1993;1749-1754.
22. Revets H., Marissens D., De Wit S., Lacor P., Clumek N., Lauwers S., Zissis G. Comparative evaluation of NASBA HIV-1 RNA QT, Amplicor-HIV Monitor and Quantiplex HIV RNA Assay, three methods for the quantification of human immunodeficiency virus type 1 in plasma. J Clin Microbiol. 34:1996;1058-1064.
23. Scadden D.T., Wang Z., Groopman J.E. Quantitation of plasma human immunodeficiency virus type 1 by competitive polymerase chain reaction. J Infect Dis. 165:1992;1119-1123.
24. Schockmel G.A., Yerly S., Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acq Immune Deficiency Syndrome Hum Retrovirol. 14:1996;179-183.
25. Schuurman R., Descamps D., Jan Wverling G., Kaye S., Tijnajel J., Williams I., van Leeuwen R., Tedder R., Boucher C.A., Brun-Vezinet F., Loveday C. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 34:1996;3016-3022.
26. Semple M., Loveday C., Weller I., Tedder R. Direct measurement of viraemia in patients infected with human immunodeficiency virus type 1 and its relationship to disease progression and zidovudine therapy. J Med Virol. 35:1991;38-45.
27. Soriano V, Gomez-Cano MA, Bravor R, Castilla J, Mas A, Villaalba N, Gzlez-Lahoz. Comparison of three commercial methods for quantitation of plasma HIV-RNA in clinical specimens. In: 4th Conf Retro and Opportun Infect 1997;2179:Abstr 595. Foundation for Retrovirology and Human Health.
28. Steketee R.W., Abrams E.J., Thea D.M., Brown T.M., Lambert G., Orloof S., Weedon J., Bamji M., Schoenbaum E.E., Rapier J., Kalish M.L. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV-RNA amplification and detection. J Infect Dis. 175:1997;707-711.
29. Todd J., Yerghiazarian T., Hoo B., Detmer J., Kolberg J., White R., Wilber J., Urdea M.S. Quantitation of human immunodeficiency virus plasma RNA by branched DNA and reverse transcription coupled polymerase chain reaction assay method: A critical evaluation of accuracy and reproducibility. Serodiag Immunother Infect Dis. 6:1994;233-239.
30. Urdea M.S., Wilber J.C., Yeghiazarian T., Todd J.A., Kern D.G., Fong S.J., Besemer D., Hoo B., Sheridan P.J., Kokka R. Direct quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS. 7(Suppl 2):1993;S4-S11.
31. Vandamme A.-M., Schimt J.-C., Van Dooren S., Van Laethem K., Gobbers E., Kok W., Goubeau P., Witvroum M., Peetermans W., De Clerq E., Desmyter J. Quantification of HIV RNA in Plasma: Comparable results with the NASBA HIV-1 RNA QT and the Amplicor-HIV Monitor Test. J Acq Immune Deficiency Syndrome Hum Retrovirol. 13:1996;127-139.
32. Van Gemen B., Kievits T., Nara P.L., Huisman G., Jurriaans S., Goudsmit J., Lens P. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS. 7(Suppl 2):1993;S107-S110.
33. Verhofstede C., Fransen K., Marissens D., Verhelst R., van der Groen G., Lauwers S., Zissis G., Plum J. Isolation of HIV-1 RNA from plasma: Evaluation of eight different extraction methods. J Virol Methods. 60:1996;155-159.
34. Wang Z, MacMullen G, Spadoro J. Determination of target of quantitative standards for PCR diagnostic assays. Abstract presented at the ASM Meeting, ASM Press 1994.
35. Yen-Liberman B., Brambilla D., Jackson B., Bremer J., Coombs R., Cronin M., Herman S., Katzenstein D., Leug S., Ju Lin H., Palumbo P., Rasheed S., Todd J., Vahey M., Reichelderfer R. Evaluation of a quality assurance program for the quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group Virology Laboratories. J Clin Microbiol. 34:1996;2695-2701.